CompletedNCT06785012
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder
Researchers compared JNJ-89495120 and placebo to find out how the approaches affected depression symptoms in adults with depression.
Medication studyAges 18–64United States
Understand this study
What did researchers investigate?
Researchers compared JNJ-89495120 and placebo to find out how the approaches affected depression symptoms in adults with depression.
Who was this study for?
Listed age limits: 18 years to 64 years.
- Listed locations
- Huntsville and 43 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: December 26, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 105
- Sponsor
- Janssen Research & Development, LLC
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT06785012
- Official title
Show the full official title
A Randomized, Double-blind, Multicenter, Placebo-controlled, Proof-of-Concept Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-89495120 as Monotherapy in Adult Participants With Major Depressive Disorder (MDD)
Get this study by email
Recruitment & locations
CompletedHuntsville · Chandler · Phoenix
38 more locations
- Tucson
- Bellflower
- Encino
- Garden Grove
- Newport Beach
- Orange
- Redlands
- San Diego
- San Jose
- Santa Ana
- Temecula
- Walnut Creek
- Denver
- Fort Myers
- Hollywood
- Homestead
- Maitland
- Miami
- Pembroke Pines
- Tampa
- West Palm Beach
- Atlanta
- Decatur
- Snellville
- Chicago
- Indianapolis
- New Orleans
- Gaithersburg
- Worcester
- Brooklyn
- Cincinnati
- Columbus
- Oklahoma City
- Philadelphia
- North Charleston
- McKinney
- Clinton
- Everett
Questions about this study
What did researchers investigate?
Researchers compared JNJ-89495120 and placebo to find out how the approaches affected depression symptoms in adults with depression.
Who is behind this study?
The study sponsor is Janssen Research & Development, LLC.
Did this study involve medication?
Yes. The study involved medication, including JNJ-89495120 and Placebo.
Who was this study for?
Listed age limits: 18 years to 64 years.
